These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Response to: Breakthrough COVID-19 infections among health care workers after two doses of ChAdOx1 nCoV-19 vaccine. Niyas VKM; Arjun R QJM; 2022 Jun; 115(6):424-425. PubMed ID: 34297117 [No Abstract] [Full Text] [Related]
27. Unusual Fever, Headache, and Abdominal Pain in a Healthy Woman. Lin CY; Wang CH; Hsiao PJ Gastroenterology; 2021 Nov; 161(5):1387-1389. PubMed ID: 34339677 [No Abstract] [Full Text] [Related]
28. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622 [TBL] [Abstract][Full Text] [Related]
29. Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature. Moslemi M; Ardalan M; Haramshahi M; Mirzaei H; Sani SK; Dastgir R; Dastgir N BMC Infect Dis; 2022 Mar; 22(1):217. PubMed ID: 35241013 [TBL] [Abstract][Full Text] [Related]
30. Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination. Sheng WH; Chang SY; Lin PH; Hsieh MJ; Chang HH; Cheng CY; Yang HC; Pan CF; Ieong SM; Chao TL; Chen JP; Cheng SH; Chang SC J Formos Med Assoc; 2022 Apr; 121(4):766-777. PubMed ID: 35305895 [TBL] [Abstract][Full Text] [Related]
31. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. Soltani Hekmat A; Javanmardi K Biomed Res Int; 2021; 2021():7702863. PubMed ID: 34734086 [TBL] [Abstract][Full Text] [Related]
32. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review. Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842 [TBL] [Abstract][Full Text] [Related]
34. Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination. Robichaud J; Côté C; Côté F CMAJ; 2021 Aug; 193(34):E1341-E1344. PubMed ID: 34362727 [No Abstract] [Full Text] [Related]
35. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine. Sønderskov KM; Dinesen PT; Østergaard SD Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886 [TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Madhi SA; Koen AL; Izu A; Fairlie L; Cutland CL; Baillie V; Padayachee SD; Dheda K; Barnabas SL; Bhorat QE; Briner C; Aley PK; Bhikha S; Hermanus T; Horne E; Jose A; Kgagudi P; Lambe T; Masenya M; Masilela M; Mkhize N; Moultrie A; Mukendi CK; Moyo-Gwete T; Nana AJ; Nzimande A; Patel F; Rhead S; Taoushanis C; Thombrayil A; van Eck S; Voysey M; Villafana TL; Vekemans J; Gilbert SC; Pollard AJ; Moore PL; Kwatra G; Lancet HIV; 2021 Sep; 8(9):e568-e580. PubMed ID: 34416193 [TBL] [Abstract][Full Text] [Related]
37. Comment on: Stromal rejection in penetrating keratoplasty following COVID-19 vector vaccine (Covishield) - A case report and review of literature. Gurnani B; Kaur K Indian J Ophthalmol; 2022 Jun; 70(6):2206. PubMed ID: 35648024 [No Abstract] [Full Text] [Related]
38. An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. Maas RJ; Gianotten S; van der Meijden WAG Am J Kidney Dis; 2021 Aug; 78(2):312. PubMed ID: 33992727 [No Abstract] [Full Text] [Related]
39. Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre. Koumaki D; Krueger-Krasagakis SE; Papadakis M; Katoulis AC; Gkiaouraki I; Zografaki K; Mylonakis D; Krasagakis K J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e411-e415. PubMed ID: 35075691 [No Abstract] [Full Text] [Related]